Neural stem cells (NSC) have been shown to migrate towards damaged areas, produce trophic factors, and replace lost cells in ways that might be therapeutic for Parkinson's disease (PD). However, there is very little information on the effects of NSC on endogenous cell populations. In the current study, effects of implanted human NSC (hNSC) on endogenous tyrosine hydroxylase-positive cells (TH+ cells) after treatment with 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) were explored in nonhuman primates. After MPTP damage and in PD, the primate brain is characterized by decreased numbers of dopamine neurons in the substantia nigra (SN) and an increase in neurons expressing TH in the caudate nucleus. To determine how implanted NSC might affect these cell populations, 11 St. Kitts African green monkeys were treated with the selective dopaminergic neurotoxin, MPTP. Human NSC were implanted into the left and right caudate nucleus and the right SN of eight of the MPTP-treated monkeys. At either 4 or 7 months after NSC implants, the brains were removed and the size and number of TH+ cells in the target areas were assessed. The results were compared to data obtained from normal untreated control monkeys and to the three unimplanted MPTP-treated monkeys. The majority of hNSC were found bilaterally along the nigrostriatal pathway and in the substantia nigra, while relatively few were found in the caudate. In the presence of NSC, the number and size of caudate TH+ cells returned to non-MPTP-treated control levels. MPTP-induced and hNSC-induced changes in the putamen were less apparent. We conclude that after MPTP treatment in the primate, hNSC prevent the MPTP-induced upregulation of TH+ cells in the caudate and putamen, indicating that hNSC may be beneficial to maintaining a normal striatal environment.
INTRODUCUTION
iron and neuromelanin found in the SN, exacerbating the oxidative stress in already overburdened neurons [for review see (35) ]. MPP+ selectively kills most of the dopa-The MPTP-treated nonhuman primate model has significant advantages for studying Parkinson's disease minergic neurons of the primate SNc while leaving the dopaminergic neurons of the olfactory bulb and ventral (PD). MPTP (1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine) is neurotoxic to the dopamine neurons of the sub-tegmental area relatively unaffected. This selective neuronal death may be due to the difference in iron content stantia nigra pars compacta (SNc) and produces parkinsonian-like symptoms in monkeys, including slowed and the sequestering abilities of the vesicular monoamine and dopamine transporters by SNc dopaminergic movements and delayed movement initiation [for reviews see (16, 21) ]. MPTP crosses the blood-brain bar-neurons (14, 30, 35) . The surviving dopamine neurons in the SN, after MPTP exposure, are smaller and have a rier where it is converted into methyl-phenylpridinium (MPP+) and is taken into dopaminergic neurons via the weakened capacity to function (27) . Besides the effects on the viability of the dopamine neurons in the SN, there dopamine transporter (DAT). Once internalized, MPP+ inhibits Complex I in the mitochondrial electron trans-are also two visible effects in the caudate nucleus and putamen (the striatum). port cascade and can interact with the high levels of After MPTP treatment, immunohistochemistry for responding to functional cues designed to rescue and support surviving SN neurons, rather than replace them. tyrosine hydroxylase (TH) shows a significant hypodensity in fiber innervation of the striatum from the SN. In
In support of this hypothesis, undifferentiated NSC were found to produce significant levels of glia-derived neu-addition to this, the caudate nucleus specifically shows a significant increase in the number of TH+ and DAT+ rotrophic factor (GDNF), a factor important for the survival and maintenance of dopaminergic neurons (20,23, cells (4,9,29) . Under normal conditions, the caudate nucleus and putamen of both nonhuman primates and hu-26). The production of GDNF was not nearly as great in differentiated stem cells (20, 26) . mans contain a small number of TH+ cells, mainly along their dorsal and rostral borders (4,8, 15, 27, 29) . The TH+ Because NSCs have shown a propensity to migrate, secrete trophic factors, and differentiate, there should be cells in the striatum of nonhuman primates and humans are smaller than those found in the SN and there appear apparent effects on the endogenous neurons of the host. We used the primate MPTP-treated, dopamine-depleted to be at least two types of these cells. Most of the striatal TH+ cells (>95%) are small, uni-or bipolar neurons model of PD to address how resident neurons are being influenced by exogenous hNSC. First, our results indi-with aspiny processes ranging in diameter of 6-15 µm (4,8,29). There are also larger TH+ cells with many cate that the hNSC survive in the primate brain up to 7 months, and are probably migrating into the SN as de-spinied processes having a diameter of 10-20 µm (4,29). After MPTP treatment and in PD patients the noted by the presence of hNSC in the unimplanted SN. Furthermore, we found evidence that the hNSC produce number of TH+ cells in the caudate significantly increases and the dendritic processes lengthen (3-a significant effect on the endogenous TH+ cells of the caudate. Our data suggest that the transplantation of 5,27,29). It has not been reported whether this upregulation in TH+ cells also occurs in the putamen. The hNSC into an MPTP-stressed environment alters the size and numbers of the endogenous caudate/putaminal TH+ function of these striatal TH+ cells and the reason for their increase is unknown but it may be a compensatory cells to be more indicative of the size and numbers found in non-MPTP-treated normal controls. reaction to the loss of dopamine input from the SN.
In the present study, the MPTP monkey model was MATERIALS AND METHODS used to appraise the effects of human neural stem cell Cell Isolation and Preparation (hNSC) implants on the endogenous TH+ cells of the caudate nucleus and putamen. NSC are pluripotent cells Cells were obtained from a stable self-maintaining from the fetal central nervous system. In vitro, NSC clone of hNSC. The isolation of the cells has been dehave the potential to differentiate into glia and neurons scribed elsewhere (12). Briefly the cells were obtained (7,12,31). In vivo studies suggest that implanted NSC from the periventricular area in the telencephalon of a respond to migratory, differentiation, and other func-13-week human fetal cadaver and expanded in serumtional cues depending on local brain environment. When free medium supplemented with basic fibroblast growth implanted into the subventricular zone, NSC enter the factor and/or epidermal growth factor. Prior to transrostral migratory stream, position themselves in the olplantation, hNSCs were preincubated in culture with factory bulb, and become neurons (11, 13) . When imbromodeoxyuridine (BrdU, 10 µM) for 48 h to be identiplanted into a damaged brain, NSC possess the ability fied postmortem. Immediately prior to transplantation, to respond to more damage-specific cues (1, 25, 26) . For cells were washed, harvested, and made into a sterile example, in a model of "impaired" dopamine neuronal saline-based cell suspension (50,000-100,000 vc/µl). function, MPTP-treated mice were unilaterally implanted MPTP Treatment and Transplantation with NSC or neurospheres (clusters of free-floating NSC) into the striatum. The implanted cells migrated through-Adult male, St. Kitts African green monkeys (Chlorocebus aethiops sabaeus) from the colony at the St. out the striatum and into distant brain areas (19, 26) . Surprisingly, only 1% of NSC differentiated to replace dys-Kitts Biomedical Research Foundation (St. Kitts, West Indies) were used in accordance with the National Insti-functional dopamine neurons of the SN (19, 26) . Most NSC remained undifferentiated in the host brain, sug-tutes of Health Guide for the Care and Use of Laboratory Animals. Eleven monkeys were treated first with gesting that while migration cues were present, differentiation cues either were not available or not needed. Stri-MPTP-HCl by intramuscular injection (4-5 daily injections of 0.4-0.5 mg/kg given over a 5-day period for a atal dopamine depletion in the MPTP-treated mouse results from neuronal dysfunction and not neuronal death, cumulative dose of 2.25 mg/kg). This protocol of MPTP treatment has been shown to destroy a significant num-as seen in humans and primates. MPTP-treated mice show neurochemical and behavioral recovery within ber of nigrostriatal dopaminergic neurons (10). Three and a half to 6 months later, eight monkeys were trans-days after MPTP administration (32,33). Thus, in the above studies, the undifferentiated NSC may have been planted with hNSCs in both the left and right caudate and in the right SN. For each transplant site, 1 million a similar fashion using the same selected slides as the cell counting. Using a MicroSuite imaging system (Olym-cells were implanted at a rate of 1 µl per minute (10-30 µl per injection). Three animals were "sham" trans-pus), digital images of TH+ cells found in the caudate nucleus and putamen were collected. Approximately plants, in which monkeys were placed into the stereotaxic device, but no hNSC were implanted. All MPTP-20-60 caudate neurons and 3-10 putamen neurons were recorded for each animal. Using Image Pro software the treated monkeys were immunosuppressed (cyclosporine, 0.6 mg/kg daily). At 4 months (n = 3) and 7 months (n area of each neural cell body was measured [Scion Corp; developed at the U.S. National Institutes of Health (http:// = 5) posttransplant, monkeys were overdosed with pentobarbital and perfused with ice-cold physiological sa-rsb.info.nih.gov/nih-image)]. Because a different number of cells was counted for each area and each animal, line followed by 4% paraformaldehyde. Brains were removed and immersed in paraformaldehyde for 12 h and a weighted ANOVA was used to determine statistically significant differences in cell body area. A Fisher LSD then stored in 30% sucrose buffer until sectioning.
test was used for post hoc comparisons.
Immunohistochemistry, Cell Measures, and Statistics
RESULTS Brains were frozen and sectioned into 50-µm parasagittal sections on a sliding blade microtome. Every Before evaluating the effects of hNSC on the endogenous TH+ cells of the caudate nucleus and putamen, we fourth section was processed free-floating for BrdU, to identify the presence and location of the hNSC. In adja-first verified that the hNSC were still present in the brain. Figure 1 shows BrdU+ cells found in the left, un-cent sections, TH immunohistochemistry was used to identify dopamine neurons. Briefly, sections were incu-implanted SN. This picture is representative of both the 4-month and 7-month implanted monkeys. The presence bated overnight in primary antibody (BrdU, BD Biosciences 1:50; TH, Chemicon, 1:1000 in 5% goat serum;
of hNSC in the unimplanted SN indicates that the hNSC are migrating into this area. Very few hNSC were found and 0.3% Triton X-100 in phosphate-buffered saline). Immunopositive cells were visualized with the diamino-in the caudate nucleus, despite being the location of bilateral hNSC implants, suggesting that the hNSC found benzidine-nickel chromagen (DAB-nickel).
Starting at an anatomically similar level for both in the unimplanted SN probably originated from the implantation site of the caudate. It is also possible that the sides of each animal (approximately 3.2 mm from midline), five slides were taken at 500-µm intervals. A hNSC may have migrated from the implanted SN to the unimplanted SN. Basic cell counts of the BrdU+ cells counter, blinded to the treatment of the animals, counted all TH+ cells found in the caudate and putamen in all found in the area of the SN indicate that several tens of thousands of hNSC survived through 7 months (Fig. 2 ). five slides. Cell numbers were expressed as the total number of TH+ cells in a 2-mm parasagittal expanse and Ongoing analyses of survival, migration, and differentiation of these hNSC are in progress and will be presented calculated from the number of TH+ cells per tissue section (50 µm) multiplied by the total number of sections in another paper (6,34). While previous studies have reported on two types of (40 sections) over 2 mm. The left and right sides were counted separately. A repeated measures ANOVA with TH+ cells in the primate caudate and putamen, a third type of cell also was found. In contrast to morphologic Fisher LSD post hoc test was used to determine significant differences at p < 0.05 (Statistica, Statsoft Inc., features of the SN dopamine neurons (Fig. 3D ), many small bipolar neurons (type I; Fig. 3A) , and rare multi-Tulsa, OK). Basic counts of BrdU+ cells found in a 60mm 2 area around the SN derived from three slides sepa-polar spiny-processed neurons (type II; Fig. 3B ) were located in the caudate nucleus and putamen. In addition rated by 800 µm are presented here using an unbiased fractionator stereological method.
to these two cell types, a third TH+ cell was also observed (type III, Fig. 3C ). The type III neurons had The control group (n = 8) received neither MPTP nor transplants. Four of the controls were obtained from our smooth or varicosed processes, like type I neurons, but typically had three or more processes and larger cell library of archived monkey tissue. These tissue sections, which previously had been sectioned into 50-µm coronal bodies. The perikarya also were less spherical and more polygonal. The type III neurons had characteristics of slices and immunostained for TH, were included in the measures of TH+ cell body areas, but not for total cell both type I and type II cells. All three types of TH+ cells were found in both the non-MPTP-and MPTP-counts because of their coronal orientation. Four additional controls, which were sectioned parasagittally, treated monkey caudate nucleus and putamen. The relative proportions of the three cell types were found to were processed and immunostained along with the tissue from the experimental groups. These control animals be the same in control and MPTP-treated monkeys and between the caudate and the putamen; however, the pu-were included in cell body areas and total cell numbers.
The cell body areas of TH+ cells were determined in tamen had approximately one third the number of TH+ cells as the caudate nucleus. Because there were three size or number of type I neurons in the caudate nucleus between 4-month MPTP/4-month hNSC and 6-month subpopulations, we examined the potential trophic effects of hNSC on each striatal TH+ cell type. MPTP/7-month hNSC implanted groups. By 4 months, the effects on TH+ cell number and size resulting from hNSC implanted into the caudate nucleus and SN of MPTP-treated monkeys significantly affected the endog-the presence of hNSC are seen in the caudate nucleus. There were no additional changes that could be seen at enous TH+ cells, specifically the type I neurons. Consistent with earlier reports (4,29), after MPTP treatment the 7 months postimplantation, suggesting that the effects of hNSC on endogenous TH+ cells occur early and are number of type I TH+ cells increased ( Fig. 4A ) and were also smaller than neurons in control animals (Fig. 4B ).
maintained at least through 7 months. MPTP and hNSC effects on the less frequent type II MPTP-treated monkeys implanted with hNSC had a significantly smaller post-MPTP increase in type I neurons and type III neurons were less consistent. MPTP treatment did not alter the number or size of the multipolar in both the caudate nucleus and putamen, which were closer to the numbers found in normal control monkeys. type II neurons in the caudate nucleus ( Fig. 4C and D) .
In the putamen, the number of type II neurons increased, In the caudate nucleus, the presence of hNSC also restored the size of the type I cells to near control sizes but did not change in size in MPTP-only treated monkeys ( Fig. 5C and D) . The type II neurons found in (Fig. 4B ). There were no significant differences in the hNSC-implanted monkeys typically were unchanged in pensatory action to the loss of nigrostriatal dopaminergic neurons. It is apparent that hNSC implanted into MPTP-both the caudate nucleus and putamen from MPTP treatment alone, except in the left caudate of 4-month MPTP/ treated, dopamine-depleted monkeys have a significant, probably trophic, effect on the endogenous TH+ cells of 4-month hNSC monkeys, which showed a significant increase in the number of type II, and in the left caudate the striatum. We surmise a trophic effect simply because in the presence of hNSC the aberrations in number and of 6-month MPTP/7-month hNSC monkeys where the cell size significantly increased. While statistically sig-size of striatal TH+ cells created by MPTP toxicity were reversed. The most prominent striatal TH+ cells, type I, nificant the meaning of these dichotomous results is unclear.
consistently showed an increase in number and a decrease in size after MPTP treatment, particularly in the MPTP treatment tended to increase the number of type III neurons in the caudate nucleus while leaving caudate nucleus. In monkeys with hNSC implanted bilaterally into the caudate nucleus and unilaterally (right their size unchanged. In the presence of hNSC implants, the number of cells was unchanged compared with the side) into the SN, the type I neurons increased in size and reduced their numbers to levels similar with non-MPTP-only-treated animals. However, their cell bodies grew significantly compared to control and MPTP-only-treated controls. This effect was seen as early as 4 months posttransplant and was maintained through at least 7 treated animals ( Fig. 4E and F) . Alternatively, in the putamen, MPTP treatment did not change the number of months. There were no differences between 4-month and 7-month implanted animals, nor between the right type III neurons ( Fig. 5E ) but did increase their size. This is exactly opposite the effects seen in the caudate (double implants) and left (striatal implant only) sides. This may indicate a "ceiling" effect for trophic activity nucleus, where size remained relatively unchanged. The presence of hNSC did not significantly affect the MPTP-in caudate TH+ type I neurons. Thus, these cells are influenced quickly (4 months) by a minimal number of induced changes in the putamen.
hNSC (single implant). Adding more hNSC or allowing DISCUSSION them a longer time to integrate into the environment of the caudate nucleus may not be necessary to achieve In this study we identified three types of TH+ cells (types I, II, and III) in the caudate nucleus and putamen maximum effect. We found a large population of hNSC residing around of control and MPTP-treated monkeys based on their discrete morphology. The function of these subtypes re-and within the implanted SN and the unimplanted SN, while very few hNSC were found in the caudate. The mains uncertain, but their alterations following MPTP treatment suggests that they may be involved in a com-presence of hNSC in the unimplanted SN and so few in Figure 2 . hNSC were found in equal quantities on both sides of the SN for both the 4-month and 7-month groups. hNSC were implanted bilaterally into the caudate but only in the right SN. After only 4 months, 46,000 BrdU+ cells could be found in the area of the SN. By 7 months, nearly twice as many cells can be seen in this area. It is clear from these data that the hNSC are migrating into the unimplanted SN side.
the caudate suggests that the hNSC migrated down from the caudate into the SN. Alternatively, the cells could have migrated from the contralateral SN. The effects we found on the endogenous TH+ cells of the caudate, so distal from the actual location of most of the hNSC, further suggest that the hNSC are having a trophic effect. It maybe possible that the hNSC are facilitating the survival and function of the remaining SN neurons to a level where the changes induced by MPTP in the caudate nucleus are reversed. Changes in the putamen were less pronounced. MPTP treatment had a less defined effect on TH+ cells of the putamen, which may overshadow the statistical appearance of an effect of the hNSC implants. The putamen had significantly fewer TH+ cells compared with the caudate nucleus and, with its proximity to the SN, the putamen or the DA connections to it may be less influenced by MPTP than the more distally located caudate nucleus. In the species of monkeys we used, it has been reported that the caudate nucleus is more impacted than the putamen (10). This may account for the increased variability found in the putaminal measures, which prevented statistically significant results. In PD, unlike MPTP-treatment, the putamen is substantially more affected than the caudate nucleus (17, 18, 24, 28) . Because of this, the influence of implanted hNSC on the putamen, might be more apparent in PD, resembling the "normalizing" effects that hNSC have in the caudate nucleus after MPTP treatment.
A possible trophic effect of hNSC, as indicated by the reversal of MPTP-induced changes, shown in this study is supported by a previous report in which undifferentiated NSC produced GDNF (20, 26) . In an MPTP mouse model, the undifferentiated NSC were most often found adjacent to dopamine neurons and only rarely was a NSC-originated dopamine neuron found. In addition, the dopamine-depleted mice implanted unilaterally with FACING COLUMN Figure 3 . The three types of TH+ cells that are found in the caudate nucleus. (A) Type I neurons are small (11.32 ± 0.17 µm diameter) and primarily bipolar with processes that can be varicose or smooth. More than 95% of the caudate/putamen TH+ cells are type I. (B) Type II neurons are larger (15.45 ± 0.47 µm diameter) with multiple spiny processes. These neurons make up less than 1% of the TH+ cells in the primate caudate nucleus and putamen. (C) Type III neurons are smaller (13.71 ± 0.36 µm diameter) than type II, with fewer and smoother processes. On average, less than 5% of TH+ cells in the monkey caudate nucleus and putamen are type III. shams showed a significant increase in the number of type I cells. MPTP-treated monkeys implanted with hNSC had fewer type I cells and were not significantly different from controls (no MPTP, no hNSC). No significant differences were found between 4month and 7-month animals, F(3, 11) = 4.06, p < 0.05. (B) While cell numbers increased in shams, their cell sizes were significantly smaller than type I cells found in controls. MPTP-treated animals that received hNSC implants showed an increase in type I cell size comparable to controls, F(6, 965) = 64.96, p < 0.00. (C) There was a trend for all MPTP-treated animals to show an increase in the number of type II cells but that increase reached significance only on the left side of 4-month animals compared with controls, F(3, 11) = 3.84, p < 0.05. (D) As with cell numbers, no consistent changes in cell size based on MPTP treatment or hNSC implants were found in type II cells. Only in 7-month animals and only on the left was the increase in cell size greater than controls, F(6, 109) = 4.40, p < 0.01. (E) MPTP-treated animals had an increase in the number of type III cells, but no significant differences were found as a result of hNSC implants, F(3, 11) = 3.39, p > 0.05. (F) hNSC implants had significantly larger type III cells than controls, F(6, 207) = 5.40, p < 0.001] *Significantly different than control measures, #significant difference between right and left sides, p < 0.05. The size of cells found on the right side of 7-month animals were significantly larger than any other cells found. The type I neurons found on the left (single caudate implant) were not significantly different between any groups. (C) In the type II neurons of the putamen, there was a significant increase in their numbers as a result of MPTP treatment, F(3, 10) = 4.11, p < 0.05. The presence of hNSC did not alter the number of type II neurons. (D) No changes consistent to MPTP treatment or hNSC implants were found in the size of type II neurons of the putamen. A significant decrease was found only on the right side of 4-month animals, F(6, 52) = 5.50, p < 0.001. (E) No significant differences were found in the number of type III neurons in the putamen between the four treatment groups, F(3, 10) = 1.80, p > 0.05. (F) MPTP treatment increased the size of type III neurons compared with controls, F(6, 147) = 16.09, p < 0.001. In the presence of hNSC the size of type III neurons was reduced but they were still significantly bigger than controls. *Significantly different than control measures, #significant difference between right and left sides, **significantly greater than all other groups, p < 0.05. rotations, characteristic of striatal dopamine imbalance (26) . The behavioral and neuroanatomical data of the dopamine-depleted mouse study suggests that the undif-REFERENCES ferentiated NSC functionally support the surviving do-
